Mayne Pharma Group Limited (ASX: MYX) announced on 10 December 2018, regarding the change of director’s interest notice.
As per the notice, the name of the entity under which there is a change in the director's interest is “Mastermyne Group Limited” with ABN 96 142 490 579.
Mastermyne Group Limited will act as an agent for the director under section 205G of the Corporation Act; director Anthony Salvatore Caruso received date of the last notice on 21 November 2017. However, there is a change in the director’s interest in the securities which it holds.
The director Anthony Salvatore Caruso has a direct interest in the securities. On 20 November 2018, there were changes were made under which director, Anthony Salvatore Caruso’s the interest will be held indirectly as a trustee of the MAD Investment Trust, where he will act as a beneficiary. Anthony Salvatore Caruso & Helen Annette Caruso will hold an indirect interest as a trustee of the Caruso Super Fund where Mr. Caruso is a member. The interest will be held indirectly by Off-Line Investments Pty Ltd as a trustee of the Caruso Super Fund, where Mr. Caruso is a member.
Earlier, under Ordinary fully paid shares of MYE, the director had 1,221,001 shares, 48,692 shares, and 150,000 shares. Under Performance Rights, securities held by the director were 713,286 shares and 256,737 shares.
After the change made on 20 November 2018, additional 117,959 numbers of performance right has been acquired by the director. The issue of the performance right was approved at the AGM on 20 November 2018.
The company has shown a positive performance since its inception. The performance since its inception remains 656.66%. Within ten years, the company’s performance was outstanding. In 5 years, the company maintained a positive return of 48.72%. Since last year, the performance of the company was 50.40%. However, for the past three months, the performance of the company is negative.
For the financial year ending on 30 June 2018, the company made a net profit of $5.588 million. The company holds a net asset of $53.758 million which implies that the company is can meet its long-term obligations. The total current asset of the company is $46.401 million, and the total current liabilities of the company is $29.028 million which is a proof that the company is in a position to maintain its working capital and also take care of short-term obligations. The total shareholder’s equity was $53.758 million.
There was a net cash inflow of $10.356 million from the operating activities of the company. Here, the primary source of cash inflow was through the cash receipt from the customers as well as cash generated through the operations.
There was a net outflow of $9.480 million from the investing activities of the company. Here, the primary source of cash outflow was through the acquisition of property, plant, and equipment.
There was a net cash outflow of $0.629 million from the investing activities of the company. Here, the primary source of cash outflow was in the form of repayment of borrowings.
By the end of FY2018, there was a cash deficiency of A$0.520 million.
By the end of trading on 10 December 2018, the market price of the share was A$0.885 with the stock holding a market capitalization of A$1.48 billion.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.